Advertisement
Research Article| Volume 27, ISSUE 2, P230-235, March 2009

Glycemic index, glycemic load, wellness and beauty: the state of the art

      Abstract

      The glycemic index (GI) is a ranking system for carbohydrates' effect on blood glucose levels. It compares available carbohydrates gram for gram in individual foods, providing a numerical, evidence-based index of postprandial glycemia. The glycemic load (GL) is a ranking system for carbohydrate content in food portions based on their GI and the portion size. These two markers increasingly are being used to prevent typical diseases of the Western world, including type 2 diabetes mellitus, cardiovascular disease, obesity, metabolic syndrome, and acne. Data on the efficacy of GI and GL in the treatment of Western population diseases are discussed and critically evaluated, with a particular focus on acne and other skin disorders.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Liu S.
        • Willett W.C.
        Dietary glycemic load and atherothrombotic risk.
        Curr Atheroscler Rep. 2002; 4: 454-461
        • Jenkins D.J.
        • et al.
        Glycemic index of foods: a physiological basis for carbohydrate exchange.
        Am J Clin Nutr. 1981; 34: 362-366
        • Fernandes G.
        • Velangi A.
        • Wolever T.M.
        Glycemic index of potatoes commonly consumed in North America.
        J Am Diet Assoc. 2005; 105: 557-562
        • Foster-Powell K.
        • Holt S.H.
        • Brand-Miller J.C.
        International table of glycemic index and glycemic load values: 2002.
        Am J Clin Nutr. 2002; 76: 5-56
        • Willett W.
        • Manson J.
        • Liu S.
        Glycemic index, glycemic load, and risk of type 2 diabetes.
        Am J Clin Nutr. 2002; 76: 274S-280S
        • Salmeron J.
        • Manson J.E.
        • Stampfer M.J.
        • Colditz G.A.
        • Wing A.L.
        • Willett W.C.
        Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women.
        JAMA. 1997; 277: 472-477
        • Salmeron J.
        • Ascherio A.
        • Rimm E.B.
        • et al.
        Dietary fiber, glycemic load, and risk of NIDDM in men.
        Diabetes Care. 1997; 20: 545-550
        • Ford E.S.
        • Liu S.
        Glycemic index and serum high-density lipoprotein cholesterol concentration among adults.
        Arch Intern Med. 2001; 161: 572-576
        • Liu S.
        • Manson J.E.
        • Stampfer M.J.
        • et al.
        Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women.
        Am J Clin Nutr. 2001; 73: 560-566
        • Liu S.
        • Manson J.E.
        • Buring J.E.
        • Stampfer M.J.
        • Willett W.C.
        • Ridker P.M.
        Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.
        Am J Clin Nutr. 2002; 75: 492-498
        • Liu S.
        • Willett W.C.
        • Stampfer M.J.
        • et al.
        A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women.
        Am J Clin Nutr. 2000; 71: 1455-1461
        • Ludwig D.S.
        Dietary glycemic index and the regulation of body weight.
        Lipids. 2003; 38: 117-121
        • Slabber M.
        • Barnard H.C.
        • Kuyl J.M.
        • Dannhauser A.
        • Schall R.
        Effects of a low-insulin-response, energy-restricted diet on weight loss and plasma insulin concentrations in hyperinsulinemic obese females.
        Am J Clin Nutr. 1994; 60: 48-53
        • Bouche C.
        • Rizkalla S.W.
        • Luo J.
        • et al.
        Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men.
        Diabetes Care. 2002; 25: 822-828
        • Spieth L.E.
        • Harnish J.D.
        • Lenders C.M.
        • et al.
        A low-glycemic index diet in the treatment of pediatric obesity.
        Arch Pediatr Adolesc Med. 2000; 154: 947-951
        • Berra B.
        • Montorfano G.
        • Berselli P.
        • Rizzo A.M.
        Diet, exercise, long chain polyunsaturated omega-3 fatty acids and the metabolic syndrome.
        Prog Nutr. 2007; 9: 124-133
        • Cordain L.
        • Lindeberg S.
        • Hurtado M.
        • Hill K.
        • Eaton B.
        • Brand-Miller B.
        Acne vulgaris—a disease of Western civilization.
        Arch Dermatol. 2002; 138: 1584-1590
        • Schaefer O.
        When the Eskimo comes to town.
        Nutr Today. 1971; 6: 8-16
        • Steiner P.
        Necropsies on Okinawans: anatomic and pathologic observations.
        Arch Pathol. 1946; 42: 359-380
        • Smith R.N.
        • Mann N.J.
        • Braue A.
        • Mächeläinen H.
        • Varigos J.A.
        A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial.
        Am J Clin Nutr. 2007; 86: 107-115
        • Kaymak Y.
        • Adisen E.
        • Ilter N.
        • Bideci A.
        • Gurler D.
        • Celik B.
        ADietary Glycemic Index and glucose, insulin-like growth factor-1, insulin-like growth factor binding protein 3, and leptin levels in patients with acne.
        J Am Acad Dermatol. 2007; 57: 819-823
        • Becker S.W.
        • Obermeyer M.E.
        Modern Dermatology and Syphilology. 2nd ed. JB Lippincott Co, Philadelphia (Pa)1947: 590-595
        • Ormsby O.S.
        • Montgomery H.
        Diseases of the Skin. 8th ed. Lea & Febiger, Philadelphia (Pa)1954: 1365
        • Sutton Jr, R.L.
        Diseases of the Skin. 11th ed. Mosby Co, St Louis (Mo)1956: 683-690
        • Tan J.
        • Vasey K.
        • Fung K.
        Beliefs and perceptions of patients with acne.
        J Am Acad Dermatol. 2001; 44: 439-445
        • Eichenfield L.F.
        • Leyden J.J.
        Acne: current concepts of pathogenesis and approach to rational treatment.
        Pediatrician. 1991; 18: 218-223
        • Thiboutot D.M.
        Acne: an overview of clinical research findings.
        Dermatol Clin. 1997; 15: 97-109
        • Webster G.F.
        Acne vulgaris: state of the science.
        Arch Dermatol. 1999; 135: 1101-1102
        • Green J.
        • Sinclair R.D.
        Perceptions of acne vulgaris in final-year medical student written examination answers.
        Australas J Dermatol. 2001; 42: 98-101
        • Holt S.A.
        • Brand Miller J.C.
        • Petocz P.
        An insulin index of foods: the insulin demand generated by 100-kJ portions of common foods.
        Am J Clin Nutr. 1997; 66: 1264-1276
        • Daly M.E.
        • Vale C.
        • Walker M.
        • Alberti K.G.
        • Mathers J.C.
        Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications.
        Am J Clin Nutr. 1997; 66: 1072-1085
        • Zammit V.A.
        • Waterman I.J.
        • Topping D.
        • McKay G.
        Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance.
        J Nutr. 2001; 131: 2074-2077
        • Nam S.Y.
        • Lee E.J.
        • Kim K.R.
        • et al.
        Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone.
        Int J Obes Relat Metab Disord. 1997; 21: 355-359
        • Attia N.
        • Tamborlane W.V.
        • Heptulla R.
        • et al.
        The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
        J Clin Endocrinol Metab. 1998; 83: 1467-1471
        • Brismar K.
        • Fernqvist-Forbes E.
        • Wahren J.
        • Hall K.
        Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes.
        J Clin Endocrinol Metab. 1994; 79: 872-878
        • Holly J.M.P.
        The physiological role of IGFBP-1.
        Acta Endocrinol. 1991; 124: 55-62
        • Ferry R.J.
        • Cerri R.W.
        • Cohen P.
        Insulin-like growth factor binding proteins: new proteins, new functions.
        Horm Res. 1999; 51: 53-67
        • Rudman S.M.
        • Philpott M.P.
        • Thomas G.A.
        • Kealey T.
        The role of IGF-I in human skin and its appendages: morphogen as well as mitogen?.
        J Invest Dermatol. 1997; 109: 770-777
        • Bol K.K.
        • Kiguchi K.
        • Gimenez-Conti I.
        • Rupp T.
        • DiGiovanni J.
        Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.
        Oncogene. 1997; 14: 1725-1734
        • Aizawa H.
        • Niimura M.
        Elevated serum insulin-like growth factor-I (IGF-1) levels in women with postadolescent acne.
        J Dermatol. 1995; 22: 249-252
        • Aizawa H.
        • Niimura M.
        Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne.
        J Dermatol. 1996; 23: 526-529
        • Cordain L.
        • Eades M.
        • Eades M.
        yperinsulinemic diseases of civilization: more than just Syndrome X.
        Comp Biochem Physiol. 2003; 136: 95-112
        • Valentinis B.
        • Bhala A.
        • DeAngelis T.
        • Baserga R.
        • Cohen P.
        The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene.
        Mol Endocrinol. 1995; 9: 361-367
        • Vacaresse N.
        • Lajoie-Mazenc I.
        • Auge N.
        • et al.
        Activation of epithelial growth factor receptor pathway by unsaturated fatty acids.
        Circ Res. 1999; 85: 892-899
        • Edmondson S.R.
        • Murashita M.M.
        • Russo V.C.
        • Wraight C.J.
        • Werther G.A.
        Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGF1.
        J Cell Physiol. 1999; 179: 201-207
        • Evans T.R.
        • Kaye S.B.
        Retinoids: present role and future potential.
        Br J Cancer. 1999; 80: 1-8
        • Yang Q.
        • Mori I.
        • Shan L.
        • et al.
        Biallelic inactivation of retinoic acid receptor B2 gene by epigenetic change in breast cancer.
        Am J Pathol. 2001; 158: 299-303
        • Liu B.
        • Lee H.Y.
        • Weinzimer S.A.
        • et al.
        Direct functional interaction between insulin-like growth factor-binding protein-3 and retionoid X receptor-alpha regulate transcriptional signaling and apoptosis.
        J Biol Chem. 2000; 275: 33607-33613
        • Wendling O.
        • Chambon P.
        • Mark M.
        Retinoid X receptors are essential for early mouse development and placentogenesis.
        Proc Natl Acad Sci U S A. 1999; 96: 547-551
        • Chiba H.
        • Clifford J.
        • Metzger D.
        • Chambon P.
        Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells.
        Mol Cell Biol. 1997; 17: 3013-3020
        • Grimberg A.
        • Cohen P.
        Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.
        J Cell Physiol. 2000; 183: 1-9
        • Thacher S.M.
        • Vasudevan J.
        • Chandraratna R.A.
        Therapeutic applications for ligands of retinoid receptors.
        Curr Pharm Des. 2000; 6: 25-58
        • Barbieri R.L.
        • Smith S.
        • Ryan K.J.
        The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism.
        Fertil Steril. 1988; 50: 197-212
        • Cara J.F.
        Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production.
        Horm Res. 1994; 42: 49-54
        • Bebakar W.M.
        • Honour J.W.
        • Foster D.
        • Liu Y.L.
        • Jacobs H.S.
        Regulation of testicular function by insulin and transforming growth factor-beta.
        Steroids. 1990; 55: 266-270
        • De Mellow J.S.
        • Handelsman D.J.
        • Baxter R.C.
        Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells.
        Acta Endocrinol. 1987; 115: 483-489
        • Crave J.C.
        • Lejeune H.
        • Brebant C.
        • Baret C.
        • Pugeat M.
        Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells.
        J Clin Endocrinol Metab. 1995; 80: 1283-1289
        • Singh A.
        • Hamilton-Fairley D.
        • Koistinen R.
        • et al.
        Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells.
        J Endocrinol. 1990; 124: R1-R3
        • Pugeat M.
        • Crave J.C.
        • Elmidani M.
        • et al.
        Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin.
        J Steroid Biochem Mol Biol. 1991; 40: 841-849
        • Vermeulen A.
        • Kaufman J.M.
        • Giagulli V.A.
        Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
        J Clin Endocrinol Metab. 1996; 81: 1821-1826
        • Pfeilschifter J.
        • Scheidt-Nave C.
        • Leidig-Bruckner G.
        • et al.
        Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women.
        J Clin Endocrinol Metab. 1996; 81: 2534-2540
        • Erfurth E.M.
        • Hagmar L.E.
        • Saaf M.
        • Hall K.
        Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men.
        Clin Endocrinol (Oxf). 1996; 44: 659-664
        • Zouboulis C.C.
        • Xia L.
        • Akamatsu H.
        • et al.
        The human sebocyte culture model provides new insights into development and management of seborrhoea and acne.
        Dermatology. 1998; 196: 21-31
        • Deplewski D.
        • Rosenfield R.L.
        Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation.
        Endocrinology. 1999; 140: 4089-4094
        • Klinger B.
        • Anin S.
        • Silbergeld A.
        • Eshet R.
        • Laron Z.
        Development of hyperandrogenism during treatment with insulin-like growth hormone factor-I (IGF-I) in female patients with Laron syndrome.
        Clin Endocrinol (Oxf). 1998; 48: 81-87
        • Thiboutot D.
        • Gilliland K.
        • Light J.
        • Lookingbill D.
        Androgen metabolism in sebaceous glands from subjects with and without acne.
        Arch Dermatol. 1999; 135: 1041-1045
        • Franks S.
        Polycystic ovary syndrome.
        N Engl J Med. 2003; 13: 853-861
        • Dunaif A.
        • Segal K.
        • Shelley D.
        • Green G.
        • Dorbrjansky A.
        Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome.
        Diabetes. 1989; 38: 1165-1174
        • Bourne S.
        • Jacobs A.
        Observations on acne, seborrhoea, and obesity.
        BMJ. 1956; 1: 1268-1270
        • Fulton J.
        • Plewig G.
        • Kligman A.
        Effect of chocolate on acne vulgaris.
        JAMA. 1969; 210: 2071-2074
        • Mackie B.
        • Mackie L.
        Chocolate and acne.
        Aust J Dermatol. 1974; 15: 103-109
        • Anderson P.
        Foods as the cause of acne.
        Am J Fam Pract. 1971; 3: 102-103
        • Margin P.
        • Pond D.
        • Smith W.
        • Watson A.
        A systematic review of the evidence for ‘myths and misconceptions’ in acne management: diet, face-washing and sunlight.
        Fam Pract. 2005; 22: 62-70
        • Chiu A.
        • Chon S.
        • Kimball A.
        The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress.
        Arch Dermatol. 2003; 139: 897-900
        • Adebamowo C.
        • Spiegelman D.
        • Danby F.
        • Frazier A.
        • Willett W.
        • Holmes M.
        High school dietary dairy intake and teenage acne.
        J Am Acad Dermatol. 2005; 52: 207-214